Bourgeois Y - Search Results

1

Cre-mediated recombination in the skin melanocyte lineage.

Delmas V, Martinozzi S, Bourgeois Y, Holzenberger M, Larue L. Delmas V, et al. Among authors: bourgeois y. Genesis. 2003 Jun;36(2):73-80. doi: 10.1002/gene.10197. Genesis. 2003. PMID: 12820167

2

Spatiotemporal gene control by the Cre-ERT2 system in melanocytes.

Yajima I, Belloir E, Bourgeois Y, Kumasaka M, Delmas V, Larue L. Yajima I, et al. Among authors: bourgeois y. Genesis. 2006 Jan;44(1):34-43. doi: 10.1002/gene.20182. Genesis. 2006. PMID: 16419042

3

Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Berlin I, Denat L, Steunou AL, Puig I, Champeval D, Colombo S, Roberts K, Bonvin E, Bourgeois Y, Davidson I, Delmas V, Nieto L, Goding CR, Larue L. Berlin I, et al. Among authors: bourgeois y. Mol Cell Biol. 2012 Apr;32(7):1237-47. doi: 10.1128/MCB.06257-11. Epub 2012 Jan 30. Mol Cell Biol. 2012. PMID: 22290434 Free PMC article.

4

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF. Nemati F, et al. Among authors: bourgeois y. Clin Cancer Res. 2000 May;6(5):2075-86. Clin Cancer Res. 2000. PMID: 10815935

5

[Drug sensitivity of bronchial small cell cancers transplanted to nude mice. Expression of the mdr1 gene and correlation with clinical practice. Effects of antagonists].

Poupon MF, Arvelo F, Bourgeois Y, Jacrot M. Poupon MF, et al. Among authors: bourgeois y. Bull Cancer. 1994 Dec;81 Suppl 2:86s-87s. Bull Cancer. 1994. PMID: 7727867 French. No abstract available.

6

Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.

Némati F, Daniel C, Arvelo F, Legrier ME, Froget B, Livartowski A, Assayag F, Bourgeois Y, Poupon MF, Decaudin D. Némati F, et al. Among authors: bourgeois y. Anticancer Drugs. 2010 Jan;21(1):25-32. doi: 10.1097/CAD.0b013e3283300a29. Anticancer Drugs. 2010. PMID: 19823076

7

Mitochondria-bound hexokinase as target for therapy of malignant gliomas.

Oudard S, Poirson F, Miccoli L, Bourgeois Y, Vassault A, Poisson M, Magdelénat H, Dutrillaux B, Poupon MF. Oudard S, et al. Among authors: bourgeois y. Int J Cancer. 1995 Jul 17;62(2):216-22. doi: 10.1002/ijc.2910620218. Int J Cancer. 1995. PMID: 7622299

8

Src kinase contributes to the metastatic spread of carcinoma cells.

Boyer B, Bourgeois Y, Poupon MF. Boyer B, et al. Among authors: bourgeois y. Oncogene. 2002 Apr 4;21(15):2347-56. doi: 10.1038/sj.onc.1205298. Oncogene. 2002. PMID: 11948418

9

Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody in human tumors.

Decaudin D, Beurdeley-Thomas A, Nemati F, Miccoli L, Pouillart P, Bourgeois Y, Gonçalves RB, Rouillard D, Poupon MF. Decaudin D, et al. Among authors: bourgeois y. Exp Cell Res. 2001 Aug 15;268(2):162-8. doi: 10.1006/excr.2001.5287. Exp Cell Res. 2001. PMID: 11478842

10

Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates.

Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, Arriagada R, Le Chevalier T. Poupon MF, et al. Among authors: bourgeois y. J Natl Cancer Inst. 1993 Dec 15;85(24):2023-9. doi: 10.1093/jnci/85.24.2023. J Natl Cancer Inst. 1993. PMID: 7902445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters